SpringerLink
Log in

Evaluation of Hypertension in Childhood Diseases

  • Living reference work entry
  • First Online:
Pediatric Nephrology

  • 359 Accesses

Abstract

Evaluation of hypertension in the pediatric age group should be guided by the patient age and severity of hypertension at presentation and whether the hypertension is sustained or transient. Severe hypertension (stage 2) should always be treated promptly, even before definitive evaluation. The most common causes of hypertension differ by age group (Table 1), so after basic screening evaluation, the specific evaluation of hypertension will be dictated by the most likely underlying diagnoses (Fig. 1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  1. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555–76.

    Article  Google Scholar 

  2. Bartosh SM, Aronson AJ. Childhood hypertension: an update on etiology, diagnosis and treatment. Pediatr Clin North Am. 1999;46:235–52.

    Article  CAS  PubMed  Google Scholar 

  3. Anyaegbu EI, Dharnidharka VR. Hypertension in the teenager. Pediatr Clin North Am. 2014;61:131–51.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Ellis D, Miyashita Y. Primary hypertension and special aspects of hypertension in older children and adolescents. Adolesc Health Med Ther. 2011;2:45–62.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Ingelfinger JR. The child or adolescent with elevated blood pressure. N Engl J Med. 2014;370:2316–25.

    Article  PubMed  CAS  Google Scholar 

  6. Flynn JT. The changing face of pediatric hypertension in the era of the childhood obesity epidemic. Pediatr Nephrol. 2013;28:1059–66.

    Article  PubMed  Google Scholar 

  7. Rosner B, Cook NR, Daniels S, et al. Childhood blood pressure trends and risk factors for high blood pressure. The NHANES Experience 1988–2008. Hypertension. 2013;62:247–54.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Members of the 1996 Working Group were Falkner B, Daniels SR, Loggie JMH, Horan MJ, Prineas RJ, Rosner B, Sinaiko AR. Update on the 1987 Task force report on high blood pressure in children and adolescents: a working group report from the national high blood pressure education program. Pediatrics. 1996;98:649–58.

    Google Scholar 

  9. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA. 2003;289:2560–72.

    Article  CAS  PubMed  Google Scholar 

  10. James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults. Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507–20.

    Google Scholar 

  11. Kent AL, Keeskes Z, Shadbolt B, Falk M. Blood pressure in the first year of life in healthy infants born at term. Pediatr Nephrol. 2007;22:1743–9.

    Article  PubMed  Google Scholar 

  12. Dione JM, Abitbol CL, Flynn JT. Hypertension in infancy: diagnosis, management and outcome. Pediatr Nephrol. 2012;27:17–32.

    Article  Google Scholar 

  13. Members of the 1987 Task Force were Horan MJ, Falkner B, Kimm SYS, Loggie JMH, Prineas RJ, Rosner B, Hutchinson J, Lauer R, Mueller S, Riopel DA, Sinaiko A, Weidman WH. Report of the second task force on blood pressure control in children – 1987. Pediatrics. 1987;79:1–25.

    Google Scholar 

  14. Park MK, Menard SW. Schoolfield J. Oscillometric blood pressure standards for children. Pediatr Cardiol. 2005;26:601–7.

    Article  CAS  PubMed  Google Scholar 

  15. Flynn JT, Pierce CB, Miller ER, et al. Reliability of resting blood pressure measurement and classifications using an oscillometric device in children with chronic kidney disease. J Pediatr. 2012;160:434–40.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Barba G, Buck C, Bammann K, et al. Blood pressure reference values for European non-overweight school children: the IDEFICS study. Int J Obes (Lond). 2014;38:S48–56.

    Article  Google Scholar 

  17. Wong S-N, Tz Sung RY, Leung LC. Validation of three oscillometric blood pressure devices against auscultatory mercury sphygmomanometer in children. Blood Press Monit. 2006;11:281–91.

    Article  PubMed  Google Scholar 

  18. Flynn JT, Daniels SR, Hayman LL, et al. Update: ambulatory blood pressure monitoring in children and adolescents. A scientific statement from the American Heart Association. Hypertension. 2014;63:1116–35.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Chaudhuri A. Pediatric ambulatory blood pressure monitoring: diagnosis of hypertension. Pediatr Nephrol. 2013;28:995–9.

    Article  PubMed  Google Scholar 

  20. Swartz SJ, Srivaths P, Croix B, et al. Cost-effectiveness of ambulatory blood pressure monitoring in the initial evaluation of hypertension in children. Pediatrics. 2008;122:1177–81.

    Article  PubMed  Google Scholar 

  21. Davis ML, Ferguson MA, Zachariah JP. Clinical predictors and impact of ambulatory blood pressure monitoring in pediatric hypertension referrals. J Am Soc Hypertens. 2014;8:660–7.

    Article  PubMed  Google Scholar 

  22. Sanders BP, Portman RJ, Ramey RA, et al. Hypertension during reduction of long-term steroid therapy in young subjects with asthma. J Allergy Clin Immunol. 1992;89:816–21.

    Article  CAS  PubMed  Google Scholar 

  23. Ferdinand KC. Substance abuse and hypertension. J Clin Hypertens. 2000;2:37–40.

    Google Scholar 

  24. Klein-Schwartz W, McGrath J. Poison centers’ experience with methylphenidate abuse in preteens and adolescents. J Am Acad Child Adolesc Psychiatry. 2003;42:288–94.

    Article  PubMed  Google Scholar 

  25. Savoca MR, Evans CD, Wilson ME, et al. The association of caffeinated beverages with blood pressure in adolescents. Arch Pediatr Adolesc Med. 2004;158:473–7.

    Article  PubMed  Google Scholar 

  26. Law CM, Sheill AW, Newsome CA, et al. Fetal, infant, and childhood growth and adult blood pressure: a longitudinal study from birth to 22 years of age. Circulation. 2002;105:1088–92.

    Article  CAS  PubMed  Google Scholar 

  27. Ponzio C, Palomino Z, Puccini RF, et al. Does low birth weight affect the presence of cardiometabolic risk factors in overweight and obese children ? Eur J Pediatr. 2013;172:1687–92.

    Article  CAS  PubMed  Google Scholar 

  28. Sipola-Leppanen M, Vaarasmaki M, Tikanmaki M, et al. Cardiovascular risk factors in adolescents born premature. Pediatrics. 2014;134:e1072–81.

    Article  PubMed  Google Scholar 

  29. Vora CK, Mansoor GA. Herbs and alternative therapies: relevance to hypertension and cardiovascular diseases. Curr Hypertens Rep. 2005;7:275–80.

    Article  CAS  PubMed  Google Scholar 

  30. Jalili J, Askeroglu U, Alleyne B, Guyuron B. Herbal products that may contribute to hypertension. Plast Reconstr Surg. 2013;131:168–73.

    Article  CAS  PubMed  Google Scholar 

  31. Williams KM, Shah AN, Morrison D, Sinha MD. Hypertensive retinopathy in severely hypertensive children: demographic, clinical, and ophthalmoscopic findings from a 30-year British cohort. J Pediatr Ophthalmol Strabismus. 2013;50:222–8.

    Article  PubMed  Google Scholar 

  32. Siegler RL, Brewer ED, Corneli HM, et al. Hypertension first seen as facial paralysis. Pediatrics. 1991;87:387–9.

    CAS  PubMed  Google Scholar 

  33. Lewis VE, Peat DS, Tizard EJ. Hypertension and facial palsy in middle aortic syndrome. Arch Dis Child. 2001;85:240–1.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. Daniels SR, Loggie JM, McEnery PT, et al. Clinical spectrum of intrinsic renovascular hypertension in children. Pediatrics. 1987;80:698–704.

    CAS  PubMed  Google Scholar 

  35. Schwartz GJ. Height: the missing link in estimating glomerular filtration rate in children and adolescents. Nephrol Dial Transplant. 2014;29:944–7.

    Article  PubMed Central  PubMed  Google Scholar 

  36. Carman TL, Olin JW, Czum J. Noninvasive imaging of the renal arteries. Urol Clin North Am. 2001;28:815–26.

    Article  CAS  PubMed  Google Scholar 

  37. Chhadia S, Cohn RA, Vural G, Donaldson JS. Renal Doppler evaluation in the child with hypertension: a reasonable screening discriminator? Pediatr Radiol. 2013;43:1549–56.

    Article  PubMed  Google Scholar 

  38. Castelli PK, Dillman JR, Kershaw DB, et al. Renal sonography with Doppler for detecting suspected pediatric renin-mediated hypertension – is it adequate? Pediatr Radiol. 2014;44:42–9.

    Article  PubMed  Google Scholar 

  39. Yanik M, Feig DI. Serum urate: a biomarker or treatment target in pediatric hypertension ? Curr Opin Cardiol. 2013;28:433–8.

    PubMed  Google Scholar 

  40. Viazzi F, Antolini L, Giussani M, et al. Serum uric acid and blood pressure in children at cardiovascular risk. Pediatrics. 2013;132:e93–9.

    Article  PubMed  Google Scholar 

  41. Deal JE, Snell ME, Barratt TM, et al. Renovascular disease in childhood. J Pediatr. 1992;121:378–84.

    Article  CAS  PubMed  Google Scholar 

  42. Tullus K, Brennan E, Hamilton G, et al. Renovascular hypertension in children. Lancet. 2008;371:1453–63.

    Article  CAS  PubMed  Google Scholar 

  43. Lagomarsino E, Orellana P, Munoz J, et al. Captopril scintigraphy in the study of arterial hypertension in pediatrics. Pediatr Nephrol. 2004;19:66–70.

    Article  PubMed  Google Scholar 

  44. Reusz G, Kis E, Cseprekal O, et al. Captopril-enhanced renal scintigraphy in the diagnosis of pediatric hypertension. Pediatr Nephrol. 2010;25:185–9.

    Article  PubMed  Google Scholar 

  45. Adelman RD. Long-term follow-up of neonatal renovascular hypertension. Pediatr Nephrol. 1987;1:36–41.

    Article  Google Scholar 

  46. Adelman RD, Morrell RE. Coarctation of the abdominal aorta and renal artery stenosis related to an umbilical artery catheter placement in a neonate. Pediatrics. 2000;106:E36.

    Article  CAS  PubMed  Google Scholar 

  47. Marks SK, Tullus K. Update on imaging for suspected renovascular hypertension in children and adolescents. Curr Hypertens Rep. 2012;14:591–5.

    Article  CAS  PubMed  Google Scholar 

  48. Srinivasan A, Krishnamurthy G, Fontalvo-Herazo L, et al. Angioplasty for renal artery stenosis in pediatric patients: an 11-year retrospective experience. J Vasc Interv Radiol. 2010;21:1672–80.

    Article  PubMed  Google Scholar 

  49. Booth C, Preston R, Clark G, et al. Management of renal vascular disease in neurofibromatosis type I and the role of percutaneous transluminal angioplasty. Nephrol Dial Transplant. 2002;17:1235–40.

    Article  PubMed  Google Scholar 

  50. Fossali E, Signorini E, Intermite RC, et al. Renovascular disease and hypertension in children with neurofibromatosis. Pediatr Nephrol. 2000;14:806–10.

    Article  CAS  PubMed  Google Scholar 

  51. Shroff R, Roebuck DJ, Gordon I, et al. Angioplasty for renovascular hypertension in children: 20-year experience. Pediatrics. 2006;118:268–75.

    Article  PubMed  Google Scholar 

  52. Huang Y, Duncan AA, McKusick MA, et al. Renal artery intervention in pediatric and adolescent patients: a 20-year experience. Vasc Endovascular Surg. 2008;41:490–9.

    Article  Google Scholar 

  53. Colyer JH, Ratnayaka K, Slack MC, Kanter JP. Renal artery stenosis in children: therapeutic percutaneous balloon and stent angioplasty. Pediatr Nephrol. 2014;29:1067–74.

    Article  PubMed  Google Scholar 

  54. Liang CD, Wu CJ, Fang CY, et al. Endovascular stent placement for management of total renal artery occlusion in a child. J Invasive Cardiol. 2002;14:32–5.

    PubMed  Google Scholar 

  55. Glockner JF, Vrtiska TJ. Renal MR and CT angiography: current concepts. Abdom Imaging. 2007;32:407–20.

    Article  PubMed  Google Scholar 

  56. Castelli PK, Dillman JR, Smith EA, et al. Imaging of renin-mediated hypertension in children. Am J Roentgenol. 2013;200:W661–72.

    Article  Google Scholar 

  57. Rountas C, Vlychou M, Vassiou K, et al. Imaging modalities for renal artery stenosis in suspected renovascular hypertension: prospective intraindividual comparison of color Doppler US, CT angiography, GD-enhanced MR angiography, and digital subtraction angiography. Ren Fail. 2007;29:295–302.

    Article  CAS  PubMed  Google Scholar 

  58. Kurian J, Epelman M, Darge K, et al. The role of CT angiography in the evaluation of pediatric renovascular hypertension. Pediatr Radiol. 2013;43:490–501.

    Article  PubMed  Google Scholar 

  59. Perazella MA, Rodby RA. Gadolinium use in patients with kidney disease: a cause for concern. Semin Dial. 2007;20:179–85.

    Article  PubMed  Google Scholar 

  60. Shellock FG, Spinazzi A. MRI safety update 2008: Part I, MRI contrast agents and nephrogenic systemic fibrosis. AJR Am J Roentgenol. 2008;191:1129–39.

    Article  PubMed  Google Scholar 

  61. Ledneva E, Karie S, Launay-Vacher V, et al. Renal safety of gadolinium-based contrast media in patients with chronic renal insufficiency. Radiology. 2009;250:618–28.

    Article  PubMed  Google Scholar 

  62. Mustafa AE, Bloom DA, Valentini RP, et al. MR angiography in the evaluation of a renovascular cause of neonatal hypertension. Pediatr Radiol. 2006;36:158–61.

    Article  PubMed  Google Scholar 

  63. Goonasekera CDA, Shah V, Wade AM, et al. The usefulness of renal vein renin studies in hypertensive children: a 25-year experience. Pediatr Nephrol. 2002;17:943–9.

    Article  PubMed  Google Scholar 

  64. Martinez-Maldonado M. Pathophysiology of renovascular hypertension. Hypertension. 1991;17:707–19.

    Article  CAS  PubMed  Google Scholar 

  65. Pickering TG, Sos TA, James GD. Comparison of renal vein renin activity in hypertensive patients with stenosis of one or both renal arteries. J Hypertens. 1985;3 Suppl 3:S291–3.

    CAS  Google Scholar 

  66. Fry WJ, Ernst BC, Stanley JC, et al. Renovascular hypertension in the pediatric patient. Arch Surg. 1973;107:692–8.

    Article  CAS  PubMed  Google Scholar 

  67. Makker SP, Moorthy B. Fibromuscular dysplasia of renal arteries. An important cause of renovascular hypertension in children. J Pediatr. 1979;95:940–5.

    Article  CAS  PubMed  Google Scholar 

  68. Plouin P-F, Perdu J, Batide-Alanore A, et al. Fibromuscular dysplasia. Orphanet J Rare Dis. 2007;2:28–35.

    Article  PubMed Central  PubMed  Google Scholar 

  69. Han M, Criado E. Renal artery stenosis and aneurysms associated with neurofibromatosis. J Vasc Surg. 2005;41:539–43.

    Article  PubMed  Google Scholar 

  70. Ingelfinger JR, Newburger JW. Spectrum of renal anomalies in patients with Williams syndrome. J Pediatr. 1991;119:771–3.

    Article  CAS  PubMed  Google Scholar 

  71. Rose C, Wessel A, Pankau R, et al. Anomalies of the abdominal aorta in Williams-Beuren syndrome – another cause of arterial hypertension. Eur J Pediatr. 2001;160:655–8.

    Article  CAS  PubMed  Google Scholar 

  72. Bouchireb K, Boyer O, Bonnet D, et al. Clinical features and management of arterial hypertension in children with Williams-Beuren syndrome. Nephrol Dial Transplant. 2010;25:434–8.

    Article  PubMed  Google Scholar 

  73. Gao J, Ng A, Shih G, et al. Intrarenal color duplex ultrasonography: a window to vascular complications of renal transplants. J Ultrasound Med. 2007;26:1403–18.

    PubMed  Google Scholar 

  74. Mutze S, Turk I, Schonberger B, et al. Colour-coded duplex sonography in the diagnostic assessment of vascular complications after kidney transplantation in children. Pediatr Radiol. 1997;27:898–902.

    Article  CAS  PubMed  Google Scholar 

  75. Heemann U, Lutz J. Pathophysiology and treatment options of chronic renal allograft damage. Nephrol Dial Transplant. 2013;28:2438–46.

    Article  CAS  PubMed  Google Scholar 

  76. Steinbrecher HA, Malone PS. Wilms tumour and hypertension: incidence and outcome. Br J Urol. 1995;76:241–3.

    Article  CAS  PubMed  Google Scholar 

  77. Londe S. Causes of hypertension in the young. Pediatr Clin North Am. 1978;25:55–8.

    CAS  PubMed  Google Scholar 

  78. Alpert BS, Bain HH, Balfe JW. Role of the renin-angiotensin-aldosterone system in hypertensive children with coarctation of the aorta. Am J Cardiol. 1979;43:828–31.

    Article  CAS  PubMed  Google Scholar 

  79. Soler R, Rodriquez E, Requejo I, et al. Magnetic resonance imaging of congenital abnormalities of the thoracic aorta. Eur Radiol. 1998;8:540–6.

    Article  CAS  PubMed  Google Scholar 

  80. Lim DS, Ralston MA. Echocardiographic indices of Doppler flow patterns compared with MRI or angiographic measurements to detect significant coarctation of the aorta. Echocardiography. 2002;19:55–60.

    Article  PubMed  Google Scholar 

  81. de Roos A, Roest AAW. Evaluation of congenital heart disease by magnetic resonance imaging. Eur Radiol. 2000;10:2–6.

    Article  PubMed  Google Scholar 

  82. Godart F, Labrot G, Devos P, et al. Coarctation of the aorta: comparison of aortic dimensions between conventional MR imaging, 3D MR angiography, and conventional angiography. Eur Radiol. 2002;12:2034–9.

    Article  PubMed  Google Scholar 

  83. Rupprecht T, Nitz W, Wagner M, et al. Determination of the pressure gradient in children with coarctation of the aorta by low-field magnetic resonance imaging. Pediatr Cardiol. 2002;23:127–31.

    Article  CAS  PubMed  Google Scholar 

  84. Hu X-H, Huang G-Y, Pa M, et al. Multidetector CT angiography and 3D reconstruction in young children with coarctation of the aorta. Pediatr Cardiol. 2008;29:726–31.

    Article  PubMed  Google Scholar 

  85. Sen PK, Kinare SG, Engineer SD, et al. The middle aortic syndrome. Br Heart J. 1963;25:610–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  86. Sethna CB, Kaplan BS, Cahill AM, et al. Idiopathic mid-aortic syndrome in children. Pediatr Nephrol. 2008;23:1135–42.

    Article  PubMed  Google Scholar 

  87. Criado E, Izquierdo L, Lujan S, et al. Abdominal aortic coarctation, renovascular hypertension, and neurofibromatosis. Ann Vasc Surg. 2002;16:363–7.

    Article  PubMed  Google Scholar 

  88. Radford DJ, Pohlner PG. The middle aortic syndrome: an important feature of Williams’ syndrome. Cardiol Young. 2000;10:597–602.

    Article  CAS  PubMed  Google Scholar 

  89. Eronen M, Peippo M, Hiippala A, et al. Cardiovascular manifestations in 75 patients with Williams syndrome. J Med Genet. 2002;39:554–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  90. Tummulo A, Marks SD, Stadermann M, et al. Mid-aortic syndrome: long-term outcome of 36 children. Pediatr Nephrol. 2009;24:2225–32.

    Article  Google Scholar 

  91. Sybert VP. Cardiovascular malformations and complications in Turner syndrome. Pediatrics. 1998;101:E11.

    Article  CAS  PubMed  Google Scholar 

  92. Landin-Wilhelmsen K, Bryman I, Wilhelmsen L. Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome. J Clin Endocrinol Metab. 2001;86:4166–70.

    Article  CAS  PubMed  Google Scholar 

  93. Nathwani NC, Unwin R, Brook CG, et al. Blood pressure and Turner syndrome. Clin Endocrinol. 2000;52:363–70.

    Article  CAS  Google Scholar 

  94. Nathwani NC, Unwin R, Brook CG, et al. The influence of renal and cardiovascular abnormalities on blood pressure in Turner syndrome. Clin Endocrinol. 2000;52:371–7.

    Article  CAS  Google Scholar 

  95. Dillon MJ. Investigation and management of hypertension in children. A personal perspective. Pediatr Nephrol. 1987;1:59–68.

    Article  CAS  PubMed  Google Scholar 

  96. Arar MY, Hogg RJ, Arant BS, et al. Etiology of sustained hypertension in children in the southwestern United States. Pediatr Nephrol. 1994;8:186–9.

    Article  CAS  PubMed  Google Scholar 

  97. Dillon MJ, Goonasekera CDA. Reflux nephropathy. J Am Soc Nephrol. 1998;9:2377–83.

    CAS  PubMed  Google Scholar 

  98. Simoes e Silva AC, Silva JP, Diniz JS, et al. Risk of hypertension in primary vesicoureteral reflux. Pediatr Nephrol. 2007;22:459–62.

    Article  PubMed  Google Scholar 

  99. Rotin D. Role of the UPS in Liddle syndrome. BMC Biochem. 2008;9 Suppl 1:S5–11.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  100. Assadi FK, Kimura RE, Subramanian U, et al. Liddle syndrome in a newborn infant. Pediatr Nephrol. 2002;17:609–11.

    Article  PubMed  Google Scholar 

  101. Warnock DG. Liddle syndrome: genetics and mechanisms of Na + channel defects. Am J Med Sci. 2001;322:302–7.

    Article  CAS  PubMed  Google Scholar 

  102. Gordon I. Indications for 99mtechnetium dimercaptosuccinic acid scan in children. J Urol. 1987;137:464–7.

    CAS  PubMed  Google Scholar 

  103. Stokland E, Hellstrom M, Jakobsson B, et al. Imaging of renal scarring. Acta Paediatr Suppl. 1999;88:13–21.

    Article  CAS  PubMed  Google Scholar 

  104. Peters AM, Jones DH, Evans K, et al. Two routes for 99mTc-DMSA uptake into the renal cortical tubular cell. Eur J Nucl Med. 1988;14:555–61.

    Article  CAS  PubMed  Google Scholar 

  105. Ask-Upmark E, Fagerberg S. Renal arteriography in arterial hypertension. Acta Med Scand. 1965;178:577–82.

    Article  CAS  PubMed  Google Scholar 

  106. Arant BS, Sotelo-Avila C, Bernstein J. Segmental “hypoplasia” of the kidney (Ask-Upmark). J Pediatr. 1979;95:931–9.

    Article  PubMed  Google Scholar 

  107. Tash JA, Stock JA, Hanna MK. The role of partial nephrectomy in the treatment of pediatric renal hypertension. J Urol. 2003;169:625–8.

    Article  PubMed  Google Scholar 

  108. Rodd CJ, Sockalosky JJ. Endocrine causes of hypertension in children. Pediatr Clin North Am. 1993;40:149–64.

    CAS  PubMed  Google Scholar 

  109. Havekes B, Romijn JA, Eisenhofer G, et al. Update on pediatric pheochromocytoma. Pediatr Nephrol. 2009;24:943–50.

    Article  PubMed  Google Scholar 

  110. Lenders JWM, Duh Q-Y, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:1915–41.

    Article  CAS  PubMed  Google Scholar 

  111. Reddy VS, O’Neill JA, Holcomb GW, et al. Twenty-five year surgical experience with pheochromocytoma in children. Am Surg. 2000;66:1085–91.

    CAS  PubMed  Google Scholar 

  112. Eisenhofer G, Lenders JW, Linehan WM, et al. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med. 1999;340:1872–9.

    Article  CAS  PubMed  Google Scholar 

  113. Weise M, Merke DP, Pacak K, et al. Utility of plasma free metanephrines for detecting childhood pheochromocytoma. J Clin Endocrinol Metab. 2002;87:1955–60.

    Article  CAS  PubMed  Google Scholar 

  114. Leung A, Shapiro B, Hattner R, et al. Specificity of radioiodinated MIBG for neural crest tumors in childhood. J Nucl Med. 1997;38:1351–7.

    Google Scholar 

  115. Shulkin BL, Shapiro B. Current concepts on the diagnostic use of MIBG in children. J Nucl Med. 1998;39:679–88.

    CAS  PubMed  Google Scholar 

  116. Olivier P, Colarinha P, Fettich J, et al. Guidelines for radioiodinated MIBG scintigraphy in children. Eur J Nucl Med Mol Imaging. 2003;30:BP45–50.

    Article  Google Scholar 

  117. Abbi RK, McVicar M, Teichberg S, et al. Pathologic characterization of a renin-secreting juxtaglomerular cell tumor in a child and review of the pediatric literature. Pediatr Pathol. 1993;13:443–51.

    Article  CAS  PubMed  Google Scholar 

  118. Haab F, Duclos J, Guyenne T, et al. Renin secreting tumors: diagnosis, conservative surgical approach and long-term results. J Urol. 1995;153:1781–4.

    Article  CAS  PubMed  Google Scholar 

  119. Spahr J, Demers LM, Shochat SJ. Renin producing Wilms’ tumor. J Pediatr Surg. 1981;16:32–4.

    Article  CAS  PubMed  Google Scholar 

  120. Dernellis J, Panaretou M. Effects of thyroid replacement therapy on arterial blood pressure in patients with hypertension and hypothyroidism. Am Heart J. 2002;143:718–24.

    Article  CAS  PubMed  Google Scholar 

  121. Stratakis CA. Cushing syndrome in pediatrics. Endocrinol Metab Clin N Am. 2012;41:793–803.

    Article  Google Scholar 

  122. Vehaskari VM. Heritable forms of hypertension. Pediatr Nephrol. 2009;24:1929–37.

    Article  PubMed Central  PubMed  Google Scholar 

  123. Cerame BI, New MI. Hormonal hypertension in children: 11beta-hydroxylase deficiency and apparent mineralocorticoid excess. J Pediatr Endocrinol Metab. 2000;13:1537–47.

    Article  CAS  PubMed  Google Scholar 

  124. Dacou-Voutetakis C, Maniati-Christidi M, Dracopoulou-Vabouli M. Genetic aspects of congenital adrenal hyperplasia. J Pediatr Endocrinol Metab. 2001;14 Suppl 5:1303–8.

    PubMed  Google Scholar 

  125. White PC, Curnow KM, Pascoe L. Disorders of steroid 11 beta-hydroxylase isoenzymes. Endocr Rev. 1994;15:421–38.

    CAS  PubMed  Google Scholar 

  126. Winter JS, Couch RM, Muller J, et al. Combined 17-hydroxylase and 17,20-desmolase deficiencies. Evidence for synthesis of a defective cytochrome P450c17. J Clin Endocrinol Metab. 1989;68:309–16.

    Article  CAS  PubMed  Google Scholar 

  127. Winter JS. Clinical, biochemical and molecular aspects of 17-hydroxylase deficiency. Endocr Res. 1991;17:53–62.

    Article  CAS  PubMed  Google Scholar 

  128. Rebaud P, Berthier JC, Hartemann E, et al. Intracranial pressure in childhood central nervous system infections. Intensive Care Med. 1988;14:522–5.

    Article  CAS  PubMed  Google Scholar 

  129. Proulx F, Lacroix J, Farrell CA, et al. Convulsions and hypertension in children: differentiating cause from effect. Crit Care Med. 1993;21:1541–6.

    Article  CAS  PubMed  Google Scholar 

  130. Axelrod FB. Familial dysautonomia: a 47-year perspective. How technology confirms clinical acumen. J Pediatr. 1998;132:S2–5.

    Article  CAS  PubMed  Google Scholar 

  131. Axelrod FB, Goldberg JD, Ye X, et al. Survival in familial dysautonomia: impact of early intervention. J Pediatr. 2002;141:518–23.

    Article  PubMed  Google Scholar 

  132. Fernhoff PM. No pains, many gains. J Pediatr. 2002;141:470–1.

    Article  PubMed  Google Scholar 

  133. Davis S. Pregnancy in adolescents. Pediatr Clin North Am. 1989;36:665–80.

    CAS  PubMed  Google Scholar 

  134. Murdock NM. Teenage pregnancy. J Natl Med Assoc. 1998;90:135–6.

    PubMed Central  CAS  PubMed  Google Scholar 

  135. Gortzak-Uzan L, Hallak M, Press F, et al. Teenage pregnancy: risk factor for adverse perinatal outcome. J Matern Fetal Med. 2001;10:393–7.

    Article  CAS  PubMed  Google Scholar 

  136. Tabacova SA, Kimmel CA. Enalapril: pharmacokinetic/dynamic inferences for comparative developmental toxicity. A review. Reprod Toxicol. 2001;15:467–78.

    Article  CAS  PubMed  Google Scholar 

  137. Sedman AB, Kershaw DB, Bunchman TE. Recognition and management of angiotensin converting enzyme inhibitor fetopathy. Pediatr Nephrol. 1999;9:382–5.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Renal Section, Baylor College of Medicine and Texas Children’s Hospital, Houston, TX, USA

    Eileen D. Brewer M.D. & Sarah J. Swartz M.D.

Authors
  1. Eileen D. Brewer M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sarah J. Swartz M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eileen D. Brewer M.D. .

Editor information

Editors and Affiliations

  1. Children's Hospital of Wisconsin Children's Research Institute, Milwaukee, Wisconsin, USA

    Ellis D. Avner

  2. Harvard Medical School Children's Hospital Boston, Boston, Massachusetts, USA

    William E. Harmon

  3. Hôpital Necker Enfants Malades Dept. Néphrologie Pédiatrique, Paris, France

    Patrick Niaudet

  4. Wakayama Medical University Dept. Pediatrics, Wakayama City, Japan

    Norishige Yoshikawa

  5. Department of Nephrology and Urology Division of Nephrology, Children's Hospital Bambino Gesù, IRCCS, Rome, Italy

    Francesco Emma

  6. Division of Nephrology and Hypertension The Heart Institute, University of Cincinnati Cincinnati Children’s Hospital Medical C, Cincinnati, Ohio, USA

    Stuart Goldstein

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Brewer, E.D., Swartz, S.J. (2015). Evaluation of Hypertension in Childhood Diseases. In: Avner, E., Harmon, W., Niaudet, P., Yoshikawa, N., Emma, F., Goldstein, S. (eds) Pediatric Nephrology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27843-3_81-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27843-3_81-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27843-3

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation